ESPERITE is launching unique new-generation genetic tests. Risk-free, convenient, affordable and accurate tests with results available in a few days. ESPERITE eases its clients the key genetic information to personalize their health-related decisions, fostering a new culture of consumer empowerment towards a proactive approach to health.

ESPERITE, through its predictive medicine arm GENOMA SA, is at the forefront of technological and scientific innovation. ESPERITE is announcing a multimillion investment to assemble the genetic platform for clinical diagnostics in Europe. A highly efficient NGS platform with the capacity to process 75'000 samples per year.

ESPERITE signed a supply agreement with Thermo Fisher Life Technology to install satellite sequencing platforms in the countries where ESPERITE operates, all connected to its NGS Cloud.